<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" title="XSL_formatting" href="http://www.mstrust.org.uk/news/rss/rss.xsl"?><rss version="2.0"><channel><title><![CDATA[MS Trust Recent Story List]]></title><link><![CDATA[http://2008.mstrust.org.uk]]></link><description><![CDATA[]]></description><language><![CDATA[en-us]]></language><lastBuildDate><![CDATA[Fri, 3 Jul 2009 04:01:02 +0100]]></lastBuildDate><copyright><![CDATA[Multiple Sclerosis Trust, Spirella Building, Letchworth Garden City, Herts SG6 4ET]]></copyright><docs><![CDATA[http://blogs.law.harvard.edu/tech/rss]]></docs><generator><![CDATA[www.idnet.net]]></generator><ttl><![CDATA[60]]></ttl><item><title><![CDATA[Darzi says focus on long term conditions]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3112]]></link><description><![CDATA[Regions should consider shifting their attentions from waiting times to long term conditions to reflect the changing economic climate, health minister Lord Darzi has said.]]></description><pubDate><![CDATA[Wed, 1 Jul 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3112]]></guid></item><item><title><![CDATA[Why repair of brain's wiring fails]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3113]]></link><description><![CDATA[Scientists have uncovered new evidence suggesting that damage to nerve cells in people with multiple sclerosis accumulates because the body's natural mechanism for repair of the nerve coating called "myelin" stalls out.]]></description><pubDate><![CDATA[Wed, 1 Jul 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3113]]></guid></item><item><title><![CDATA[Biogen confirms new infection linked to Tysabri]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3107]]></link><description><![CDATA[Biogen Idec Inc. has reported a new case of a potentially lethal brain inflammation in a patient using its drug Tysabri, the tenth such case since the drug was reintroduced three years ago.]]></description><pubDate><![CDATA[Mon, 29 Jun 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3107]]></guid></item><item><title><![CDATA[I couldn't let him die alone]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3110]]></link><description><![CDATA[Four years ago Laura McDaid made the hardest choice of her life: to accompany her former boyfriend to Switzerland's Dignitas clinic to escape the pain of MS.]]></description><pubDate><![CDATA[Mon, 29 Jun 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3110]]></guid></item><item><title><![CDATA[Ill health forces MP to step down]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3106]]></link><description><![CDATA[Cumbrian MP David Maclean, who has multiple sclerosis, is to stand down at the next election due to his deteriorating health.]]></description><pubDate><![CDATA[Sat, 27 Jun 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3106]]></guid></item><item><title><![CDATA[Immunomodulatory treatment improves cognitive function in patients with multiple sclerosis: Presented at ENS]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3105]]></link><description><![CDATA[Patients with relapsing-remitting multiple sclerosis (RRMS) who receive glatiramer acetate (GA) or interferon (IFN) beta show a reduction in cognitive impairment and relative stability of cognitive and affective variables at 2 years.]]></description><pubDate><![CDATA[Fri, 26 Jun 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3105]]></guid></item><item><title><![CDATA[All life is precious]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3100]]></link><description><![CDATA[But I have a disease that will kill me and want the right to end my pain when I choose, says Hilary Freeman.]]></description><pubDate><![CDATA[Thu, 25 Jun 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3100]]></guid></item><item><title><![CDATA[Continuous disease-modifying treatment without interruptions provides better long-term outcomes in multiple sclerosis: Presented at ENS]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3095]]></link><description><![CDATA[Patients with multiple sclerosis (MS) who adhere to their treatment with interferon (IFN) beta-1a without interruption have lower relapse and progression rates than patients who do not adhere to their medication as regularly, said researchers here at the 19th Meeting of the European Neurological Society (ENS).]]></description><pubDate><![CDATA[Tue, 23 Jun 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3095]]></guid></item><item><title><![CDATA[Cancer drug could revolutionise MS treatment]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3097]]></link><description><![CDATA[Researchers in the UK believe a common cancer drug could revolutionise the treatment of multiple sclerosis (MS).]]></description><pubDate><![CDATA[Tue, 23 Jun 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3097]]></guid></item><item><title><![CDATA[Biogen enrolls patients in new MS trial]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3096]]></link><description><![CDATA[Biogen Idec has enrolled its first patient in a phase 3 trial for a potential multiple sclerosis treatment that, when compared with existing therapies, would reduce the number of injections patients must receive.]]></description><pubDate><![CDATA[Mon, 22 Jun 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3096]]></guid></item><item><title><![CDATA[MS sufferer who pioneered specialist treatment commits suicide]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3094]]></link><description><![CDATA[An academic who pioneered a treatment for multiple sclerosis has committed suicide because she feared being sent to a care home as her condition worsened.]]></description><pubDate><![CDATA[Sun, 21 Jun 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3094]]></guid></item><item><title><![CDATA[Biogen reports a ninth PML case from Tysabri]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3093]]></link><description><![CDATA[Cambridge [USA] based Biogen Idec Inc confirmed the ninth case of progressive multifocal leukoencephalopathy in a patient taking its multiple sclerosis treatment Tysabri since the drug was reintroduced in July 2006.]]></description><pubDate><![CDATA[Sat, 20 Jun 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3093]]></guid></item><item><title><![CDATA[Patients use MS treatment centre]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3090]]></link><description><![CDATA[More than 150 people with multiple sclerosis (MS) in Cornwall have registered with a new treatment centre since it opened eight weeks ago.]]></description><pubDate><![CDATA[Wed, 17 Jun 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3090]]></guid></item><item><title><![CDATA[Putting the health back into the NHS]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3091]]></link><description><![CDATA[Budget management and hierarchies dominate a sector sorely in need of an injection of innovation from the bottom up.]]></description><pubDate><![CDATA[Tue, 16 Jun 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3091]]></guid></item><item><title><![CDATA[NYU study may find better treatments for MS]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3092]]></link><description><![CDATA[Doctors at New York University are conducting a medical study that may determine the best treatments to slow the advancement of multiple sclerosis.]]></description><pubDate><![CDATA[Tue, 16 Jun 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3092]]></guid></item><item><title><![CDATA[Schoolboy calls for MS campaign]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3089]]></link><description><![CDATA[A teenager whose mother has multiple sclerosis is making a plea for MSPs to help reduce the number of people with the disease in Scotland.]]></description><pubDate><![CDATA[Mon, 15 Jun 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3089]]></guid></item><item><title><![CDATA[Two gene locations linked to multiple sclerosis discovered]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3087]]></link><description><![CDATA[Australian and New Zealand researchers have accelerated research into Multiple Sclerosis by discovering two new locations of genes which will help to unravel the causes of MS and other autoimmune disease.]]></description><pubDate><![CDATA[Sun, 14 Jun 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3087]]></guid></item><item><title><![CDATA[Hignell awarded CBE in honours list]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3086]]></link><description><![CDATA[Bristol Evening Post columnist, Alastair Hignell has been awarded the CBE for his services to sports commentary and raising funds to combat multiple sclerosis.]]></description><pubDate><![CDATA[Sat, 13 Jun 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3086]]></guid></item><item><title><![CDATA[Biogen says eighth patient has infection from Tysabri]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3085]]></link><description><![CDATA[Biogen Idec Inc said a patient taking its multiple sclerosis drug Tysabri was diagnosed with a life-threatening brain illness, the eighth case reported in the last year.]]></description><pubDate><![CDATA[Fri, 12 Jun 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3085]]></guid></item><item><title><![CDATA[Two medical meetings (ACTRIMS and CMSC) focus on MS risk factors and quality of life issues]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3083]]></link><description><![CDATA[Reports of the  14th annual meeting of ACTRIMS (Americas Committee for Treatment and Research in MS) and the CMSC (Consortium of MS Centers) annual meeting]]></description><pubDate><![CDATA[Wed, 10 Jun 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3083]]></guid></item><item><title><![CDATA[New hotline for carers launched]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3081]]></link><description><![CDATA[A one-stop information and advice service for the unsung army of carers who look after ill, frail or disabled friends and relatives was officially launched today by Care Services Minister Phil Hope.]]></description><pubDate><![CDATA[Wed, 10 Jun 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3081]]></guid></item><item><title><![CDATA['Family comes first' - carer, 15]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3079]]></link><description><![CDATA[The problems faced by young carers are highlighted in reports by Ofsted in England and the Children's Commissioner in Wales. So what is a childhood of care really like?]]></description><pubDate><![CDATA[Tue, 9 Jun 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3079]]></guid></item><item><title><![CDATA[Health Bill: MPs back NHS direct payments amid concerns]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3080]]></link><description><![CDATA[MPs backed legislation to extend direct payments to health services, but called for greater clarity on how the system would work, in a House of Commons debate yesterday.]]></description><pubDate><![CDATA[Tue, 9 Jun 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3080]]></guid></item><item><title><![CDATA[Most carers 'hit breaking point']]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3076]]></link><description><![CDATA[The pressure of being a carer has forced three out of four of them to "breaking point", according to a poll.]]></description><pubDate><![CDATA[Sun, 7 Jun 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3076]]></guid></item><item><title><![CDATA[Looking for clues inside the brain]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3072]]></link><description><![CDATA[To the background hum of freezers Dr Steve Gentleman, a neuropathologist at Imperial College, is performing a dissection.]]></description><pubDate><![CDATA[Fri, 5 Jun 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3072]]></guid></item><item><title><![CDATA[Breastfeeding associated with a reduced risk of relapse in women with multiple sclerosis]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3074]]></link><description><![CDATA[Women with multiple sclerosis who breastfeed exclusively for at least two months appear less likely to experience a relapse within a year after their baby's birth, according to a report posted online today that will appear in the August print issue of <em>Archives of Neurology</em>, one of the JAMA/Archives journals.]]></description><pubDate><![CDATA[Fri, 5 Jun 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3074]]></guid></item><item><title><![CDATA[Hydrangeas and MS]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3075]]></link><description><![CDATA[Researchers say a drug made from the roots of the hydrangea could treat several common diseases, the <em>Daily Mail</em> reported.]]></description><pubDate><![CDATA[Fri, 5 Jun 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3075]]></guid></item><item><title><![CDATA[High doses of vitamin D could cut relapse rate among MS sufferers]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3067]]></link><description><![CDATA[Powerful new evidence about the ability of vitamin D to stem a wide range of diseases has brought the prospect of a nationwide programme to prescribe it in Scotland as a dietary supplement significantly closer.]]></description><pubDate><![CDATA[Tue, 2 Jun 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3067]]></guid></item><item><title><![CDATA[MS woman 'facing dilemma']]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3068]]></link><description><![CDATA[A woman with multiple sclerosis is facing an "impossible dilemma" over ending her life because of confusion over the law, Law Lords have been told.]]></description><pubDate><![CDATA[Tue, 2 Jun 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3068]]></guid></item><item><title><![CDATA[Access to trains and buses demand]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3066]]></link><description><![CDATA[A series of demonstrations are taking place [around Wales] to highlight the difficulties faced by disabled people accessing public transport.]]></description><pubDate><![CDATA[Mon, 1 Jun 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3066]]></guid></item><item><title><![CDATA[MHRA launches drug info debate]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3069]]></link><description><![CDATA[The UK's medicines regulatory body has launched a consultation on the European Commission's plans to change the rules on the information that drug companies can provide to patients.]]></description><pubDate><![CDATA[Mon, 1 Jun 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3069]]></guid></item><item><title><![CDATA[Is vitamin D the new wonder supplement?]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3065]]></link><description><![CDATA[Most of us don't get enough of it. But the solution - spending more time in the sun - is also the problem.]]></description><pubDate><![CDATA[Sat, 30 May 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3065]]></guid></item><item><title><![CDATA[Living with a hidden illness]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3058]]></link><description><![CDATA[Many people - including colleagues and friends I have known for a long time - do not know I have MS, writes Alison Potts.]]></description><pubDate><![CDATA[Wed, 27 May 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3058]]></guid></item><item><title><![CDATA[Online cognitive-based memory video game launches on inaugural World MS Day]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3060]]></link><description><![CDATA[MSWorld Inc, a global online support community for people living with multiple sclerosis (MS), has launched a mystery-themed, memory-based video game, titled "The Case of the Missing Matches," in recognition of the first World MS Day.]]></description><pubDate><![CDATA[Wed, 27 May 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3060]]></guid></item><item><title><![CDATA[Multiple sclerosis patients benefit from diabetes drug]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3061]]></link><description><![CDATA[A drug currently FDA-approved for use in diabetes shows some protective effects in the brains of patients with relapsing remitting multiple sclerosis, researchers at the University of Illinois at Chicago College of Medicine report in a study currently available online in the <em>Journal of Neuroimmunology</em>.]]></description><pubDate><![CDATA[Wed, 27 May 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3061]]></guid></item><item><title><![CDATA[Danny Wallace: "I've learned to live with MS"]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3062]]></link><description><![CDATA[His face lights up when he talks about football - from recalling his glory days at Manchester United, and the goal he scored for England, to more lately, watching his six-year-old grandson showing great promise on the pitch.]]></description><pubDate><![CDATA[Tue, 26 May 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3062]]></guid></item><item><title><![CDATA[Struck down by the curse of MS - at age five: little Lucy reveals childhood toll of incurable disease]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3063]]></link><description><![CDATA[Lucy Wood is much like any other little girl. She adores Disney princesses and looking at her pony story books. Everyone knows her for her love of cuddles, and she dreams of being a pop star when she grows up.]]></description><pubDate><![CDATA[Tue, 26 May 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3063]]></guid></item><item><title><![CDATA[Woman with MS achieves a mountaineering feat]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3054]]></link><description><![CDATA[A retired school teacher with multiple sclerosis has now climbed the tallest mountains on each of the seven continents.]]></description><pubDate><![CDATA[Sat, 23 May 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3054]]></guid></item><item><title><![CDATA[Millward breaks Euro swimming record]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3052]]></link><description><![CDATA[Chippenham swimming star Stephanie Millward broke a European record at Sheffield at the weekend and has predicted she will go one better on Sunday.]]></description><pubDate><![CDATA[Fri, 22 May 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3052]]></guid></item><item><title><![CDATA[MS women aiming to do Hadrian's Wall challenge on mobility scooters]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3053]]></link><description><![CDATA[A convoy of multiple sclerosis sufferers on mobility scooters descended on Brampton this week as part of an 84-mile charity trek.]]></description><pubDate><![CDATA[Fri, 22 May 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3053]]></guid></item><item><title><![CDATA[Woman with MS climbing Mount Everest]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3049]]></link><description><![CDATA[A 52-year-old northern Wisconsin woman with multiple sclerosis is just days away from reaching the summit of Mount Everest, the world's tallest peak, fulfilling her dream of reaching the highest point on each of Earth's seven continents.]]></description><pubDate><![CDATA[Thu, 21 May 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3049]]></guid></item><item><title><![CDATA[Balancing drug's risk, rewards]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3050]]></link><description><![CDATA[MS patients welcome close monitoring of Tysabri use.]]></description><pubDate><![CDATA[Wed, 20 May 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3050]]></guid></item><item><title><![CDATA[GW Pharma files cannabis drug for MS in Europe]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3051]]></link><description><![CDATA[A pioneering cannabis-based medicine for multiple sclerosis from GW Pharmaceuticals has been filed for approval in Europe, paving the way for its potential approval at the end of 2009 or early in 2010.]]></description><pubDate><![CDATA[Wed, 20 May 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3051]]></guid></item><item><title><![CDATA[Schoolboy petitions MSPs over vitamin D link to MS]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3040]]></link><description><![CDATA[A <em>Times</em> investigation into the links between vitamin D deficiency and multiple sclerosis led a 14-year-old boy whose mother has the disease to petition Holyrood to provide a vitamin supplement to all children and pregnant women.]]></description><pubDate><![CDATA[Tue, 19 May 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3040]]></guid></item><item><title><![CDATA[Home care patient left on floor]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3041]]></link><description><![CDATA[An investigation is under way in Cornwall after a disabled woman fell and broke her hip when she was left without home care.]]></description><pubDate><![CDATA[Tue, 19 May 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3041]]></guid></item><item><title><![CDATA['I have MS but it hasn't got me']]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3042]]></link><description><![CDATA[It took some time for Karen Hynes to be diagnosed with multiple sclerosis and then another while for her to accept life with the condition.]]></description><pubDate><![CDATA[Tue, 19 May 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3042]]></guid></item><item><title><![CDATA[MS patient: The search for 'a cure']]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3039]]></link><description><![CDATA[Linda Oatley, who has multiple sclerosis, agreed to film undercover at a treatment clinic in the Dominican Republic for Panorama's Stem Cells and Miracles. Ms Oatley - who had no intention of having the untested, unproven treatment - talks about her illness, the emotions at play and the experience of meeting a doctor who says he can fix her.]]></description><pubDate><![CDATA[Mon, 18 May 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3039]]></guid></item><item><title><![CDATA[I will NOT surrender to MS: After her devastating diagnosis, one mother's story of defiance and hope]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3043]]></link><description><![CDATA[Seven months ago, Anastasia Parkes was diagnosed with multiple sclerosis. While no one can predict how she will be affected, her condition will inexorably deteriorate. Here, in a poignant account, she describes what it's like living in the shadow of disability - and her determination to carry on with life as usual...]]></description><pubDate><![CDATA[Mon, 18 May 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3043]]></guid></item><item><title><![CDATA[We won't be beaten by multiple sclerosis, vow Carlisle friends]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3044]]></link><description><![CDATA[Best friends Sarah Ransley and Maria Stalker are determined not to be beaten by multiple sclerosis.]]></description><pubDate><![CDATA[Mon, 18 May 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3044]]></guid></item><item><title><![CDATA[PM urged to help stem cell research]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3046]]></link><description><![CDATA[A charity has called on Prime Minister Gordon Brown to guarantee millions of pounds for research into stem cell therapies for multiple sclerosis.]]></description><pubDate><![CDATA[Mon, 18 May 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3046]]></guid></item><item><title><![CDATA[Where carers can find much needed support]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3045]]></link><description><![CDATA[The Times looks at the help available for carers, from free health checks to holidays and state benefits.]]></description><pubDate><![CDATA[Sat, 16 May 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3045]]></guid></item><item><title><![CDATA[Dyserth man a "prisoner in his own house"]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3027]]></link><description><![CDATA[A mum-of-two last night spoke of her family's desperation trying to get help for her severely disabled husband who has no access to basic toilet facilities.]]></description><pubDate><![CDATA[Thu, 14 May 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3027]]></guid></item><item><title><![CDATA[Biogen's Tysabri will still play a significant role in second line RRMS]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3029]]></link><description><![CDATA[Biogen Idec's Tysabri will play a significant role in the second line setting for the treatment of remitting multiple sclerosis (MS), despite looming competition from new oral agents in development, neurologists told Pharmawire.]]></description><pubDate><![CDATA[Wed, 13 May 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3029]]></guid></item><item><title><![CDATA[New MS drugs growing in popularity but are they increasing the risk of cancer?]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3030]]></link><description><![CDATA[In the first study of its kind, researchers from Canada are examining whether beta-interferon, widely used to treat multiple sclerosis (MS), increases the risk of cancer for MS patients.]]></description><pubDate><![CDATA[Wed, 13 May 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3030]]></guid></item><item><title><![CDATA[JK Rowling continues support for MS and other charities]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3028]]></link><description><![CDATA[New charity efforts from Harry Potter author JK Rowling]]></description><pubDate><![CDATA[Mon, 11 May 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3028]]></guid></item><item><title><![CDATA[Multiple sclerosis changed golfer's path but couldn't drive her from game]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3019]]></link><description><![CDATA[She'd been feeling weakness on the right side of her body and numbness on the left, but knew she was in serious trouble when she attempted an autograph.]]></description><pubDate><![CDATA[Sun, 10 May 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3019]]></guid></item><item><title><![CDATA[JK Rowling backs Shine on Scotland multiple sclerosis campaign]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3023]]></link><description><![CDATA[JK Rowling has given her support to the Shine on Scotland multiple sclerosis campaign, which was launched by 14 year old Ryan McLaughlin from Glasgow, whose mother has the condition.]]></description><pubDate><![CDATA[Sat, 9 May 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3023]]></guid></item><item><title><![CDATA[Incidence of PML with Tysabri in multiple sclerosis lower than previously thought]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3020]]></link><description><![CDATA[The risk of developing progressive multifocal leukoencephalopathy (PML), a viral brain infection, in patients with multiple sclerosis (MS) taking the drug natalizumab (Tysabri) appears to be much lower - and the infection less deadly - than previously estimated, according to new post-marketing surveillance data.]]></description><pubDate><![CDATA[Fri, 8 May 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3020]]></guid></item><item><title><![CDATA[A multiple sclerosis sufferer 'killed herself after watching a BBC drama about assisted suicide']]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3021]]></link><description><![CDATA[A multiple sclerosis sufferer killed herself after watching a BBC drama starring Julie Walters about assisted suicide, an inquest heard.]]></description><pubDate><![CDATA[Fri, 8 May 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3021]]></guid></item><item><title><![CDATA[Positive results of stem cell transplantation to treat multiple sclerosis: study may be key to unlocking a cure]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3022]]></link><description><![CDATA[An article published in the Summer 2009 edition of <em>Multiple Sclerosis Quarterly Report</em>, a joint publication of United Spinal Association and the North American Research Committee on Multiple Sclerosis (NARCOMS), highlights the positive initial results of patients who have improving neurologic function after receiving a stem cell transplant, despite no longer taking any MS medications.]]></description><pubDate><![CDATA[Fri, 8 May 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3022]]></guid></item><item><title><![CDATA[Vision compromised in MS even without symptoms]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3025]]></link><description><![CDATA[Researchers have suggested that deterioration of vision occurs in multiple sclerosis patients even without clinical manifestations such as optic neuritis.]]></description><pubDate><![CDATA[Fri, 8 May 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3025]]></guid></item><item><title><![CDATA[Multiple sclerosis sufferer 'a prisoner' in Selby because rail staff refuse to assist with mobility scooter]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3010]]></link><description><![CDATA[A disabled woman claims she has been made to feel like a "prisoner" in Selby because of difficulties in boarding trains.]]></description><pubDate><![CDATA[Mon, 4 May 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3010]]></guid></item><item><title><![CDATA[Methylprednisolone plus IFN beta and relapsing-remitting MS: the NORMIMS study]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3012]]></link><description><![CDATA[Adding oral methylprednisolone (MP) to the standard treatment of subcutaneous interferon beta-1a (IFNb-1a) substantially reduces the relapse rate in patients with relapsing-remitting multiple sclerosis (RRMS), according to a study published early online and appearing in the June print issue of <em>The Lancet Neurology</em>.]]></description><pubDate><![CDATA[Mon, 4 May 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3012]]></guid></item><item><title><![CDATA[Gel effective for women with overactive bladder]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3013]]></link><description><![CDATA[Applying a gel containing the anti-spasmodic agent oxybutynin to the skin is safe and effective for women with overactive bladder, according to a study reported here at the annual meeting of the American Urological Association.]]></description><pubDate><![CDATA[Mon, 4 May 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3013]]></guid></item><item><title><![CDATA[Natalizumab may activate herpes viruses]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3009]]></link><description><![CDATA[Oral herpes virus (HSV-1) eruptions were 3 times more likely in patients with multiple sclerosis who were taking natalizumab than in multiple sclerosis patients on no therapy, according to research presented here at the American Academy of Neurology (AAN) 61st Annual Meeting.]]></description><pubDate><![CDATA[Sun, 3 May 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3009]]></guid></item><item><title><![CDATA[Study highlights economic impact of early mobility impairment in people with multiple sclerosis]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3014]]></link><description><![CDATA[People with multiple sclerosis (MS) experience reduced income and earning potential as their mobility impairment increases, according to data collected from more than 8,100 participants of the North American Research Committee on Multiple Sclerosis (NARCOMS) database, the largest self-reported MS patient registry in the world. The data were presented at the American Academy of Neurology (AAN) 61st Annual Meeting in Seattle.]]></description><pubDate><![CDATA[Sun, 3 May 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3014]]></guid></item><item><title><![CDATA[Tablet to treat multiple sclerosis seen as huge step forward]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2999]]></link><description><![CDATA[Campaigners for the 85,000 Britons with multiple sclerosis yesterday welcomed the emergence of a drug promising to greatly alleviate symptoms of the debilitating disease.]]></description><pubDate><![CDATA[Thu, 30 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2999]]></guid></item><item><title><![CDATA[Can stem cells change the world?]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3004]]></link><description><![CDATA[How true are the claims that stem-cell research could one day lead to cures for a range of debilitating diseases and life-threatening conditions? asks Dick Ahlstrom.]]></description><pubDate><![CDATA[Thu, 30 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3004]]></guid></item><item><title><![CDATA[Gray matter under attack in multiple sclerosis: protein could provoke immune attack on several cell types]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3005]]></link><description><![CDATA[It has long been assumed that myelin is the most important target for the misdirected immune response.]]></description><pubDate><![CDATA[Thu, 30 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3005]]></guid></item><item><title><![CDATA[Risk of leukemia with multiple sclerosis drug higher than thought]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3006]]></link><description><![CDATA[The risk of developing leukemia as a side effect of a drug for multiple sclerosis (MS) is higher than previously reported, according to a study to be presented as part of the Late-breaking Science Program at the American Academy of Neurology's 61st Annual Meeting in Seattle, April 25 - May 2, 2009.]]></description><pubDate><![CDATA[Thu, 30 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3006]]></guid></item><item><title><![CDATA[Adding steroid drug to MS treatment may reduce disease activity]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3007]]></link><description><![CDATA[Using a steroid drug for multiple sclerosis (MS) in addition to an MS drug may reduce the amount of disease activity more than using the MS drug alone, according to a study presented as part of the Late-breaking Science Program at the American Academy of Neurology's 61st Annual Meeting in Seattle, April 25 - May 2, 2009.]]></description><pubDate><![CDATA[Thu, 30 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3007]]></guid></item><item><title><![CDATA[Two new drugs may fight multiple sclerosis]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3011]]></link><description><![CDATA[Study shows cladribine and fingolimod cut relapse rate in MS patients]]></description><pubDate><![CDATA[Thu, 30 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3011]]></guid></item><item><title><![CDATA[A UK Google for guidelines]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3017]]></link><description><![CDATA[As part of his review of the NHS, Ara Darzi tasked NICE with developing a one-stop shop for reliable and up-to-date advice. ]]></description><pubDate><![CDATA[Thu, 30 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3017]]></guid></item><item><title><![CDATA[Company says FTY720 beats rate of current top drug]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2990]]></link><description><![CDATA[Novartis AG said a study shows that 80-83 percent of patients taking its multiple sclerosis drug FTY720 are relapse-free compared to 69 percent of those on the leading current treatment.]]></description><pubDate><![CDATA[Wed, 29 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2990]]></guid></item><item><title><![CDATA[Research shows plasma exchange helps multiple sclerosis patients]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2998]]></link><description><![CDATA[Researchers at Aurora St. Luke's Medical Center in Milwaukee report that plasma exchange therapy or PLEX dramatically improves the health of multiple sclerosis patients who fail to respond to conventional therapies.]]></description><pubDate><![CDATA[Wed, 29 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2998]]></guid></item><item><title><![CDATA[Glutamate identified as predictor of disease progression in multiple sclerosis]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3000]]></link><description><![CDATA[UCSF researchers have identified a correlation between higher levels of glutamate, which occurs naturally in the brain as a by-product of metabolism, and greater disease burden in multiple sclerosis patients.]]></description><pubDate><![CDATA[Wed, 29 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3000]]></guid></item><item><title><![CDATA[Cancer pill 'offers MS benefits']]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3002]]></link><description><![CDATA[Courses of a common cancer drug can dramatically reduce the risk of a patient with multiple sclerosis having a relapse or deterioration, work shows.]]></description><pubDate><![CDATA[Wed, 29 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3002]]></guid></item><item><title><![CDATA[MS drug effective but safety an issue]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3003]]></link><description><![CDATA[Novartis AG said 80-83 percent of those taking its multiple sclerosis drug FTY720 are relapse-free compared with 69 percent on the leading current treatment, but it reported a new patient death.]]></description><pubDate><![CDATA[Wed, 29 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3003]]></guid></item><item><title><![CDATA["Good cholesterol" may help decrease MS inflammation, lessen disability]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2994]]></link><description><![CDATA[Could HDL, the "good cholesterol," have the same protective effect in multiple sclerosis, an inflammatory disease of the brain's white matter, as it does in heart disease, through its anti-inflammatory effects on blood vessels?]]></description><pubDate><![CDATA[Tue, 28 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2994]]></guid></item><item><title><![CDATA[Tysabri may promote healing around nerves, study says]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2997]]></link><description><![CDATA[Biogen Idec and its partner, Elan, catch a lot of heat because their fastest-growing drug for multiple sclerosis is associated with a rare, potentially fatal brain infection called PML.]]></description><pubDate><![CDATA[Tue, 28 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2997]]></guid></item><item><title><![CDATA[Children struck down with MS]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2985]]></link><description><![CDATA[Hundreds of children in the UK could be experiencing early symptoms of multiple sclerosis but are going undiagnosed because of lack of awareness, campaigners warned yesterday.]]></description><pubDate><![CDATA[Mon, 27 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2985]]></guid></item><item><title><![CDATA[Drug heralds multiple sclerosis advances]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2991]]></link><description><![CDATA[The first in a new wave of multiple sclerosis medicines, from drugmakers led by Novartis AG and Merck KGaA, may reach the market next year, making therapy more convenient for patients and boosting profits.]]></description><pubDate><![CDATA[Mon, 27 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2991]]></guid></item><item><title><![CDATA[Cladribine could face regulatory hurdles]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2992]]></link><description><![CDATA[Merck-Serono's cladribine could face regulatory hurdles regarding the risk of malignancy seen in clinical trials to date, as well as overall market limitations due to a current pregnancy category D label that the drug carries in hairy cell leukemia, physicians told Pharmawire.]]></description><pubDate><![CDATA[Mon, 27 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2992]]></guid></item><item><title><![CDATA[Anger as Euro MPs back cross-border health care]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2993]]></link><description><![CDATA[European Parliamentarians have approved controversial plans to give European Union (EU) citizens the right to seek healthcare in other EU countries more easily and be reimbursed for the costs but, they stress, this is not about the free movement of service providers.]]></description><pubDate><![CDATA[Mon, 27 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2993]]></guid></item><item><title><![CDATA[Wheelies in motion for charity first]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2983]]></link><description><![CDATA[Member's of Britain's one and only "Scooter Formation Display Team" - the Red Wheelies - are gearing up for their biggest challenge yet:  a gruelling journey along the full length of Hadrian's Wall, travelling over 84 miles in less than two weeks - all on Quingo Sport mobility scooters.]]></description><pubDate><![CDATA[Fri, 24 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2983]]></guid></item><item><title><![CDATA[Investors to eye MS drug safety at neurology meeting]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2984]]></link><description><![CDATA[Investors focus on MS oral drug safety data at the Annual Meeting of American Academy of Neurology - Seattle, April 25 to May 2]]></description><pubDate><![CDATA[Fri, 24 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2984]]></guid></item><item><title><![CDATA[Stem cells 'able to reverse symptoms of multiple sclerosis']]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2981]]></link><description><![CDATA[Scientists have been able to reverse the symptoms of multiple sclerosis using stem cells from patients' own body fat.
]]></description><pubDate><![CDATA[Thu, 23 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2981]]></guid></item><item><title><![CDATA[A UK consensus on the management of the bladder in multiple sclerosis]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2982]]></link><description><![CDATA[Bladder problems are a common and distressing aspect of multiple sclerosis. Their management is currently erratic in the UK, although the problems are highly amenable to treatment.]]></description><pubDate><![CDATA[Thu, 23 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2982]]></guid></item><item><title><![CDATA[Discovery of group of proteins associated with pediatric MS could lead to new disease diagnostics]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2977]]></link><description><![CDATA[A group of 12 proteins associated with pediatric multiple sclerosis (MS) have been discovered for the first time by a team of neurology and pathology researchers at Stony Brook University Medical Center.]]></description><pubDate><![CDATA[Wed, 22 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2977]]></guid></item><item><title><![CDATA[New hope for patients with multiple sclerosis]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2979]]></link><description><![CDATA[In a cell biology lab at UC Riverside, researchers look at the four screens of a flow cytometer, a sophisticated instrument that searches for fluorescent labeled reactions inside cells.]]></description><pubDate><![CDATA[Wed, 22 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2979]]></guid></item><item><title><![CDATA[Doctor organises major conference]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2980]]></link><description><![CDATA[A Rutherglen doctor has organised the first European Low Dose Naltrexone (LDN) conference which will be held in Glasgow on Saturday, April 25.
]]></description><pubDate><![CDATA[Wed, 22 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2980]]></guid></item><item><title><![CDATA[London charity chiefs hit back after Rowling quits MS role]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2968]]></link><description><![CDATA[The row over the running of Scotland's biggest MS charity has intensified with its UK bosses complaining that the body is failing to raise enough money or spend enough on research north of the Border.]]></description><pubDate><![CDATA[Tue, 21 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2968]]></guid></item><item><title><![CDATA[Birmingham heads major study into multiple sclerosis in children]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2969]]></link><description><![CDATA[The first major scientific study into multiple sclerosis in children in the UK has begun at Birmingham Children's Hospital to attempt to understand the debilitating condition.]]></description><pubDate><![CDATA[Tue, 21 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2969]]></guid></item><item><title><![CDATA[Few know multiple sclerosis facts]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2970]]></link><description><![CDATA[Few people know that multiple sclerosis (MS) mostly strikes people in their 20s and 30s, according to a new poll.]]></description><pubDate><![CDATA[Tue, 21 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2970]]></guid></item><item><title><![CDATA[Staying positive is now my goal]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2978]]></link><description><![CDATA[Former footballer Danny Wallace tells Adrian Monti that multiple sclerosis may slow him down but it won't beat him]]></description><pubDate><![CDATA[Tue, 21 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2978]]></guid></item><item><title><![CDATA[Genetic hope for MS and cancer patients]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2964]]></link><description><![CDATA[Scots scientists have discovered genetic "brakes" which could slow down or stop diseases such as multiple sclerosis and cancer, it was announced yesterday.]]></description><pubDate><![CDATA[Mon, 20 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2964]]></guid></item><item><title><![CDATA[MS centre set to move to new home]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2966]]></link><description><![CDATA[Members of the Swindon Multiple Sclerosis Therapy Centre are celebrating after they secured their new home for &#163;400,000.
]]></description><pubDate><![CDATA[Mon, 20 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2966]]></guid></item><item><title><![CDATA[The vitamin D controversy: Deficiency or symptom?]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2965]]></link><description><![CDATA[How much time do you spend in the sun? Well, according to the most recent research, not enough.]]></description><pubDate><![CDATA[Sat, 18 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2965]]></guid></item><item><title><![CDATA[Biogen Idec says sixth patient has brain disease]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2967]]></link><description><![CDATA[Biogen Idec Inc said a patient taking its multiple sclerosis drug Tysabri was diagnosed with a life-threatening brain illness, the sixth case reported since July.]]></description><pubDate><![CDATA[Sat, 18 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2967]]></guid></item><item><title><![CDATA[Low levels of vitamin D in patients with autoimmune disease may be result, not cause, of the disease]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2962]]></link><description><![CDATA[Deficiency in vitamin D has been widely regarded as contributing to autoimmune disease, but a review appearing in <em>Autoimmunity Reviews</em> explains that low levels of vitamin D in patients with autoimmune disease may be a result rather than a cause of disease and that supplementing with vitamin D may actually exacerbate autoimmune disease.]]></description><pubDate><![CDATA[Thu, 16 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2962]]></guid></item><item><title><![CDATA[Scots supporters move to break off from MS Society]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2963]]></link><description><![CDATA[JK Rowling resignation sparks campaign]]></description><pubDate><![CDATA[Thu, 16 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2963]]></guid></item><item><title><![CDATA[Health: Why I'm for a six-in-one baby jab]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2960]]></link><description><![CDATA[Miriam Stoppard writes: As a parent and grandparent, I understand concerns about giving babies vaccinations when so much misinformation is bandied about.
]]></description><pubDate><![CDATA[Tue, 14 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2960]]></guid></item><item><title><![CDATA[Vaccination fears over plan for hepatitis B jabs for babies]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2961]]></link><description><![CDATA[Babies could be routinely vaccinated against Hepatitis B in a move that could anger parents concerned about the side-effects of jabs.
]]></description><pubDate><![CDATA[Sun, 12 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2961]]></guid></item><item><title><![CDATA[I created a 'Facebook' for young sufferers of MS like me]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2959]]></link><description><![CDATA[George Pepper was devastated to learn at the age of 22 he had multiple sclerosis. But the trauma was compounded by the fact he felt utterly isolated from other young people in a similar situation.
]]></description><pubDate><![CDATA[Sat, 11 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2959]]></guid></item><item><title><![CDATA[Watchdog will investigate charity row after Rowling quits]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2958]]></link><description><![CDATA[Scotland's charity watchdog is investigating claims that the country's biggest multiple sclerosis charity has been unconstitutionally stripped of its powers by the UK parent body.]]></description><pubDate><![CDATA[Fri, 10 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2958]]></guid></item><item><title><![CDATA[Rowling quits charity over 'rift']]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2957]]></link><description><![CDATA[JK Rowling has stood down as patron of the Multiple Sclerosis Society Scotland claiming that the charity is being split by an internal row.
]]></description><pubDate><![CDATA[Thu, 9 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2957]]></guid></item><item><title><![CDATA[Patients 'are not lab rats']]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2950]]></link><description><![CDATA[Combining complementary and orthodox medicine into what is called integrated health is a controversial idea - criticised recently in the Scrubbing Up health column by Professor Edzard Ernst.  In this week's column, Dr Michael Dixon, medical director of the Prince's Foundation for Integrated Health, says patients should be able to choose what works for them.]]></description><pubDate><![CDATA[Wed, 8 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2950]]></guid></item><item><title><![CDATA[Cornwall Multiple Sclerosis Therapy Centre opens 14th April 2009]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2951]]></link><description><![CDATA[After almost seven years of fund raising Cornwall's first Multiple Sclerosis Therapy Centre gets ready to open its doors.]]></description><pubDate><![CDATA[Wed, 8 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2951]]></guid></item><item><title><![CDATA[Stem cells: will hope triumph over hype?]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2947]]></link><description><![CDATA[New research into a cure for MS is a mixed blessing for thousands of sufferers.
]]></description><pubDate><![CDATA[Mon, 6 Apr 2009 00:00:00 +0100]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=2947]]></guid></item></channel></rss>
